Table 2.
Clinical characteristics of variant carriers.
| Patient | Gene | Variant | RefSNP | Gender | Genotype | Onset of AF (age in years) |
AF Type | LVEF (%) |
Family History of AF (self-reported) |
|---|---|---|---|---|---|---|---|---|---|
| I | DMD | p.D615Efs*6 | rs752332058 | Male | Hemizygote | 28 | Persistent | >55 | No |
| II | DMD | p.D615Efs*6 | rs752332058 | Male | Hemizygote | 25 | Persistent | >55 | Yes |
| III | DMD | c.10262+1G > A | rs145603325 | Male | Hemizygote | 21 | Persistent | >55 | Yes |
| IV | DMD | c.10262+1G > A | rs145603325 | Male | Hemizygote | 28 | Persistent | >55 | No |
| V | FKTN | Chr9:108358933C > T | NA | Male | Heterozygote | 31 | Paroxysmal | NA | No |
| VI | PDLIM3 | Chr4:186425651_186425652del | NA | Female | Heterozygote | 40 | Paroxysmal | >55 | Yes |
AF, atrial fibrillation; LVEF, left-ventricular ejection fraction; NA, not available; RefSNP, reference single-nucleotide polymorphism.